Hina Waheed Chaudhry
Corporate Officer/Principal bei Icahn School of Medicine at Mount Sinai
Profil
Hina Waheed Chaudhry was the founder of VentriNova, Inc. which was founded in 2006 where she held the title of Chief Scientific Officer.
Currently, she is the Director of Cardiovascular Regenerative Medicine at Icahn School of Medicine at Mount Sinai.
Dr. Chaudhry has an undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Aktive Positionen von Hina Waheed Chaudhry
Unternehmen | Position | Beginn |
---|---|---|
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Hina Waheed Chaudhry
Unternehmen | Position | Ende |
---|---|---|
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Gründer | - |
Ausbildung von Hina Waheed Chaudhry
Harvard Medical School | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Health Technology |